Home » Newsletters » BioWorld Science

BioWorld Science

April 12, 2000

View Archived Issues

Atlantic submits IND for CT-3 to FDA; phase I trials to commence in France

Amarillo Biosciences reports phase III results for interferon alfa in Sjogren's syndrome

Celgene awarded patent for drug distribution system

Proof of concept demonstrated for PPL's transgenic BSSL

Clinical hold placed on South African study of Coviracil

Memantine improves cognition in vascular dementia patients

SangCya approved in Germany

Magainin discovers additional aminosterols with therapeutic potential

CV Therapeutics receives milestone from Biogen

Potential new diagnostic for AD presented by Axonyx

Periodontix's histatin mouthrinse reduces plaque and gingivitis

L-Arginine prevents chronic ciclosporin-induced renal dysfunction in heart transplant recipients

Canine studies demonstrate efficacy of NIP-142 in atrial flutter

Deleterious effects reported for ET antagonist immediately following MI in rat model

Japanese investigators explore uses for new chymase inhibitor SUN-C8257

NU-3108: profile of a novel nucleoside transport inhibitor

Small-molecule AICARFT inhibitors in the pipeline at Agouron

New benzodiazepinone derivatives under study at Aventis as inhibitors of bone resorption

Pfizer's new opioid receptor ligands claimed for use in painful, inflammatory and other disorders

Roche describes new ligands for the opioid-like receptor OFQ with a piperidine structure

Novel dihydrobenzopyrans exert both antiarrhythmic and antifibrillatory activities

Potent inhibition of human PDE4 reported for new Kyowa Hakko compound

Antitumor activity and pharmacokinetics of new taxoid TXD-258 discussed at ACS meeting

Aradigm announces gene therapy research collaboration with UCSF

New ocular antibiotic enters the pipeline at InSite Vision

Servier succeeds in improving antitumor activity of acronycine with S-23906-1

AVI-4126, a novel antisense compound; preclinical data presented recently support phase I/II trials

Keppra receives Swiss approval for treatment of epilepsy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.